Development and chemical stability studies of alcohol-free phenobarbital solution for use in pediatrics: a technical note.
作者信息
Jelveghari M, Nokhodchi A
机构信息
Drug Applied Research Center and Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.
出版信息
AAPS PharmSciTech. 2008;9(3):939-43. doi: 10.1208/s12249-008-9112-2. Epub 2008 Aug 7.
Abstract
摘要
相似文献
1
Development and chemical stability studies of alcohol-free phenobarbital solution for use in pediatrics: a technical note.
AAPS PharmSciTech. 2008;9(3):939-43. doi: 10.1208/s12249-008-9112-2. Epub 2008 Aug 7.
2
Formulation and stability study of an oral paediatric phenobarbital 1% solution containing hydroxypropyl-β-cyclodextrins.
Eur J Hosp Pharm. 2024 Jun 21;31(4):363-368. doi: 10.1136/ejhpharm-2022-003487.
3
Formulation and Stability of Solutions.
Int J Pharm Compd. 2016 Jan-Feb;20(1):41-5.
4
Formulation and Stability of Solutions.
Int J Pharm Compd. 2016 Mar-Apr;20(2):137-41.
5
Improved parenteral formulations for traditional antiepileptics.
PDA J Pharm Sci Technol. 1994 Nov-Dec;48(6):333-5.
6
Kaneuron: an oral solution of phenobarbital with dangerous packaging.
Prescrire Int. 2015 Apr;24(159):95.
7
Evaluation of amperometric and potentiometric titrations of phenobarbital elixir with mercury (II).
J Pharm Sci. 1961 Aug;50:661-4. doi: 10.1002/jps.2600500808.
8
SOLUBILIZATION AND STABILITY OF PHENOBARBITAL BY SOME AMINOALCOHOLS.
J Pharm Sci. 1964 Oct;53:1161-5. doi: 10.1002/jps.2600531006.
9
Primary packaging considerations in developing medicines for children: oral liquid and powder for constitution.
J Pharm Sci. 2015 Jan;104(1):52-62. doi: 10.1002/jps.24223. Epub 2014 Nov 12.
10
Solid-State and Solution Characterization of Myricetin.
AAPS PharmSciTech. 2015 Dec;16(6):1400-8. doi: 10.1208/s12249-015-0329-6. Epub 2015 May 19.
引用本文的文献
1
Preformulation and Long-Term Stability Studies of an Optimized Palatable Praziquantel Ethanol-Free Solution for Pediatric Delivery.
Pharmaceutics. 2023 Jul 30;15(8):2050. doi: 10.3390/pharmaceutics15082050.
2
Unveiling the Rational Development of Stimuli-Responsive Silk Fibroin-Based Ionogel Formulations.
Chem Mater. 2023 Jul 20;35(15):5798-5808. doi: 10.1021/acs.chemmater.3c00303. eCollection 2023 Aug 8.
3
Formulation and stability study of an oral paediatric phenobarbital 1% solution containing hydroxypropyl-β-cyclodextrins.
Eur J Hosp Pharm. 2024 Jun 21;31(4):363-368. doi: 10.1136/ejhpharm-2022-003487.
4
Drug Delivery Challenges in Brain Disorders across the Blood-Brain Barrier: Novel Methods and Future Considerations for Improved Therapy.
Biomedicines. 2021 Dec 4;9(12):1834. doi: 10.3390/biomedicines9121834.
本文引用的文献
1
Development and evaluation of a chloramphenicol hypertonic ophthalmic solution.
Indian J Pharm Sci. 2008 Jan;70(1):66-70. doi: 10.4103/0250-474X.40334.
2
Neonatal seizures: dilemmas in workup and management.
Pediatr Neurol. 2008 Jun;38(6):415-21. doi: 10.1016/j.pediatrneurol.2008.03.003.
3
Preformulation studies for an ultrashort-acting neuromuscular blocking agent GW280430A. I. Buffer and cosolvent effects on the solution stability.
Drug Dev Ind Pharm. 2002;28(2):135-42. doi: 10.1081/ddc-120002446.
4
Clinical pharmacokinetics of phenobarbital in neonates.
Eur J Pharm Sci. 2000 Dec;12(2):111-6. doi: 10.1016/s0928-0987(00)00145-7.
5
Trial of antiepilepsirine (AES) in children with epilepsy.
Brain Dev. 1999 Jan;21(1):36-40. doi: 10.1016/s0387-7604(98)00066-7.
6
Stability of alprazolam, chloroquine phosphate, cisapride, enalapril maleate, and hydralazine hydrochloride in extemporaneously compounded oral liquids.
Am J Health Syst Pharm. 1998 Sep 15;55(18):1915-20. doi: 10.1093/ajhp/55.18.1915.
7
Stability of bethanechol chloride, pyrazinamide, quinidine sulfate, rifampin, and tetracycline hydrochloride in extemporaneously compounded oral liquids.
Am J Health Syst Pharm. 1998 Sep 1;55(17):1804-9. doi: 10.1093/ajhp/55.17.1804.
8
Effect of ethanol, glycerol, and propylene glycol on the stability of phenobarbital sodium.
J Pharm Sci. 1984 Nov;73(11):1661-2. doi: 10.1002/jps.2600731149.
9
Kinetics and mechanisms in stability of drugs.
Adv Pharm Sci. 1967;2:1-94.
10
Preformulation studies of spironolactone: effect of pH, two buffer species, ionic strength, and temperature on stability.
J Pharm Sci. 1991 Jun;80(6):551-3. doi: 10.1002/jps.2600800611.
Zotero 插件